M. Peyromaure

814 total citations
44 papers, 480 citations indexed

About

M. Peyromaure is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, M. Peyromaure has authored 44 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 19 papers in Rheumatology and 16 papers in Surgery. Recurrent topics in M. Peyromaure's work include Prostate Cancer Diagnosis and Treatment (24 papers), Prostate Cancer Treatment and Research (20 papers) and Urologic and reproductive health conditions (14 papers). M. Peyromaure is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (24 papers), Prostate Cancer Treatment and Research (20 papers) and Urologic and reproductive health conditions (14 papers). M. Peyromaure collaborates with scholars based in France, Switzerland and United States. M. Peyromaure's co-authors include Marc Zerbib, Delphine Amsellem‐Ouazana, T Flam, S Conquy, Laurent Salomon, B Debré, Nicolas Barry Delongchamps, M. Soulié, Guillaume Ploussard and François Rozet and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

M. Peyromaure

39 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Peyromaure France 11 371 147 122 94 63 44 480
Gunna Aus Sweden 4 569 1.5× 153 1.0× 113 0.9× 84 0.9× 59 0.9× 8 653
Valerio Vagnoni Italy 15 446 1.2× 178 1.2× 212 1.7× 91 1.0× 105 1.7× 51 613
Raju Chelluri United States 12 313 0.8× 117 0.8× 130 1.1× 71 0.8× 30 0.5× 36 486
Mahir Maruf United States 12 345 0.9× 191 1.3× 210 1.7× 118 1.3× 218 3.5× 63 601
John Danella United States 10 272 0.7× 100 0.7× 113 0.9× 30 0.3× 26 0.4× 32 413
Eric A. Klein United States 8 374 1.0× 97 0.7× 109 0.9× 25 0.3× 26 0.4× 14 477
Michael S. Leapman United States 10 350 0.9× 73 0.5× 100 0.8× 56 0.6× 32 0.5× 21 403
D. Garrou Italy 10 336 0.9× 155 1.1× 65 0.5× 46 0.5× 161 2.6× 28 390
Paul Young United States 8 345 0.9× 112 0.8× 122 1.0× 49 0.5× 60 1.0× 19 410
P. Hammerer Germany 12 521 1.4× 290 2.0× 126 1.0× 43 0.5× 218 3.5× 49 624

Countries citing papers authored by M. Peyromaure

Since Specialization
Citations

This map shows the geographic impact of M. Peyromaure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Peyromaure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Peyromaure more than expected).

Fields of papers citing papers by M. Peyromaure

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Peyromaure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Peyromaure. The network helps show where M. Peyromaure may publish in the future.

Co-authorship network of co-authors of M. Peyromaure

This figure shows the co-authorship network connecting the top 25 collaborators of M. Peyromaure. A scholar is included among the top collaborators of M. Peyromaure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Peyromaure. M. Peyromaure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peyromaure, M., et al.. (2022). An unusual presentation of penile Mondor’s disease in an HIV-positive patient. Annals of The Royal College of Surgeons of England. 104(9). e258–e260.
2.
Huillard, Olivier, Évanguelos Xylinas, Pascaline Boudou‐Rouquette, et al.. (2019). Évaluation pluridisciplinaire préopératoire systématique en chirurgie cancérologique urologique gériatrique : faisabilité et résultats. Progrès en Urologie. 29(6). 318–325.
3.
4.
Hennequin, C., L. Cormier, Pierre Richaud, et al.. (2013). Curiethérapie exclusive du cancer de la prostate par implants permanents : indications et résultats. Revue du CC-AFU. Progrès en Urologie. 23(6). 378–385. 11 indexed citations
5.
Ploussard, Guillaume, Frédéric Staerman, Jean‐Baptiste Beauval, et al.. (2013). Predictive Factors of Oncologic Outcomes in Patients Who do not Achieve Undetectable Prostate Specific Antigen after Radical Prostatectomy. The Journal of Urology. 190(5). 1750–1756. 39 indexed citations
6.
Delongchamps, Nicolas Barry, S Conquy, Mathilde Sibony, et al.. (2013). Facteurs pronostiques des tumeurs de la voie excrétrice urinaire supérieure. Progrès en Urologie. 23(16). 1382–1388. 3 indexed citations
7.
Bastide, C., Gaëlle Fromont, C. Hennequin, et al.. (2013). Les marges chirurgicales dans le cancer de la prostate. CCAFU revue de la littérature. Progrès en Urologie. 24(6). 334–345. 6 indexed citations
8.
Bessède, Thomas, M. Soulié, Nicolas Mottet, et al.. (2012). État des lieux et implications médico-légales en France du stade pT0 du cancer de la prostate : une étude du CC-AFU. Progrès en Urologie. 22(16). 1021–1025. 2 indexed citations
9.
Delongchamps, Nicolas Barry, et al.. (2012). Cancer de la prostate de stade pT3N0 traité par prostatectomie radicale en monothérapie : résultats carcinologiques et facteurs prédictifs de récidive pT3N0 prostate cancer treated with radical prostatectomy as sole treatment: Oncological results and predictive factors of recurrence. 1 indexed citations
10.
Delongchamps, Nicolas Barry, et al.. (2012). Pose d’implants UroLift® intra-prostatiques pour hyperplasie bénigne de la prostate : résultats préliminaires des quatre premiers cas réalisés en France. Progrès en Urologie. 22(10). 590–597. 8 indexed citations
11.
Delongchamps, Nicolas Barry, et al.. (2011). Cancer de la prostate de stade pT3N0 traité par prostatectomie radicale en monothérapie : résultats carcinologiques et facteurs prédictifs de récidive. Progrès en Urologie. 22(2). 100–105. 1 indexed citations
12.
Pignot, G., Thierry Lebrét, M. Peyromaure, et al.. (2010). Cicatrisation et thérapies ciblées : quelles précautions en période périopératoire ?. Progrès en Urologie. 21(3). 166–172. 5 indexed citations
13.
Peyromaure, M., P. Mongiat-Artus, Philippe Beuzeboc, et al.. (2009). Résultats de la prostatectomie totale chez le patient âgé. Progrès en Urologie. 19. S147–S150. 2 indexed citations
14.
Camparo, Philippe, et al.. (2008). Carcinome rénal associé à une translocation MiTF/TFE : présentation de six cas chez l’adulte jeune. Progrès en Urologie. 18(5). 275–280. 14 indexed citations
15.
Zerbib, Marc, et al.. (2008). Tumeurs de vessie pTa : facteurs de récidive et de progression. Progrès en Urologie. 18(1). 35–40. 1 indexed citations
16.
Peyromaure, M., et al.. (2005). Trastuzumab (Herceptin™) in Metastatic Transitional Cell Carcinoma of the Urinary Tract: Report on Six Patients. European Urology. 48(5). 771–778. 24 indexed citations
17.
Amsellem‐Ouazana, Delphine, S Conquy, M. Peyromaure, et al.. (2005). Negative Prostatic Biopsies in Patients with a High Risk of Prostate Cancer. European Urology. 47(5). 582–586. 95 indexed citations
18.
Cornud, F., M. Peyromaure, Annick Vieillefond, et al.. (2005). Comment nous faisons une biopsie de prostate. Feuillets de Radiologie. 45(4). 297–307. 4 indexed citations
19.
Peyromaure, M., et al.. (2002). Anatomical variations in the drainage of the principal adrenal veins: the results of 88 venograms. Surgical and Radiologic Anatomy. 24(3-4). 222–225. 18 indexed citations
20.
Wind, Philippe & M. Peyromaure. (1999). [Recurrence and survival in cancer of the rectum: does it depend on the surgeon?].. PubMed. 23(3). 417–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gunna Aus Breakdown of academic impact, for papers by Valerio Vagnoni Breakdown of academic impact, for papers by Raju Chelluri Breakdown of academic impact, for papers by Mahir Maruf Breakdown of academic impact, for papers by John Danella Breakdown of academic impact, for papers by Eric A. Klein Breakdown of academic impact, for papers by Michael S. Leapman Breakdown of academic impact, for papers by D. Garrou Breakdown of academic impact, for papers by Paul Young Breakdown of academic impact, for papers by P. Hammerer
Rankless by CCL
2026